Table 1 Comparison of clinical baseline data between mild and severe xerostomia groups
Clinical | Mild xerostomia (n = 92) | Severe xerostomia (n = 163) | P | |
|---|---|---|---|---|
Sex | Man | 67 (72.8%) | 109 (66.9%) | > 0.05 |
Woman | 25 (27.2%) | 54 (33.1%) | ||
Age (years) | 48.11 ± 9.58 | 50.64 ± 9.62 | < 0.05 | |
Induction chemotherapy course | 1 | 1 | 1 | > 0.05 |
2 | 2 | 4 | ||
3 | 89 | 158 | ||
Concurrent chemotherapy course | 0 | 2 | 3 | > 0.05 |
1 | 6 | 10 | ||
2 | 84 | 150 | ||
Chemotherapy protocol | 1 | 41 | 86 | > 0.05 |
2 | 51 | 77 | ||
T stage | 1 | 3 | 6 | > 0.05 |
2 | 7 | 14 | ||
3 | 58 | 95 | ||
4 | 24 | 48 | ||
N stage | 0 | 4 | 4 | > 0.05 |
1 | 34 | 71 | ||
2 | 44 | 71 | ||
3 | 10 | 17 | ||
Stage | III | 59 | 104 | > 0.05 |
IV | 33 | 59 | ||
Dose | PGTVnx (Gy) | 69.59 ± 0.98 | 69.75 ± 0.92 | > 0.05 |
GTVnd (Gy) | 67.53 ± 2.00 | 67.21 ± 5.24 | > 0.05 |